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Abstract
For research findings to be generalized, a sample must be representative of the actual population of interest. Lower limb
amputation is most frequently performed in older patients with vascular disease, a population that is often under-
represented in research. The aim of this study was to explore the impact of selection bias by comparing characteristics from
a sample included in a prospective study of phantom pain with the actual population who underwent amputation. Only
27% of all potential patients were referred during the first year of the prospective study. The referred patients were 8 years
younger (p,0.001) and less likely to have had amputation because of a vascular condition, diabetes or infection (p = 0.003)
than those not referred. There was also a significant difference in one year survival between the groups; 67% of referred
patients survived compared with just 40% of non-referred patients (p = 0.004). The biased population in the phantom pain
study may have resulted in an underestimation of phantom pain in the original study and subsequent protective factors
should be considered within the context of the younger population reported. Selection bias is common in amputation
research, and research methods to minimize its impact must be given greater attention.
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Introduction
After a lower limb amputation (LLA), people face a number of
challenges including loss of mobility, altered body image and
phantom pain. Research to better understand these consequences
allows planning for rehabilitation and long term care and builds an
evidence base from which we can more accurately inform patients
on their expected outcomes. However, difficulties with population
sampling are frequent in amputation research and this impacts our
ability to draw accurate conclusions.
LLA is most frequently performed in older patients with
vascular disease, a population that is, for the most part, under-
represented in research [1]. Multiple co-morbidities and cognitive
decline can prevent this sub-population from meeting required
inclusion criteria. The issue of bias in studies of elderly people is
well recognized [1–4]. The same is true of amputation research,
with authors’ invariably describing selection bias within their
sample as a limitation of their study [5–11]. However, the impact
of this bias is rarely described [12]. It is important to understand
this research limitation in applying results to clinical practice and
to better design future studies.
In a prospective study of phantom limb pain, it was noted that
the population characteristics of the included sample were
considerably different from what would be expected in the LLA
population [5]. The aim of the current study is to explore the
impact of this bias on the primary outcomes (factors associated
with phantom pain) by comparing the study sample with the actual
population who underwent amputation.
Methods
Ethics Statement
The study protocol was approved by the medical ethics
committees of the University Medical Center Groningen. Patients
participating in the phantom pain study provided their written
informed consent.
Setting
Both studies were conducted in the 3 Northern provinces of the
Netherlands: Groningen, Friesland and Drenthe. Fourteen hospi-
tals in the region performed lower limb amputations, generally
under the care of a vascular surgeon. This study looks at patients
who had a first ever unilateral transtibial amputation, knee
disarticulation or transfemoral amputation between 1 January
2004 and 31 December 2004.
Phantom Pain (PP) Study
A prospective study ran from 1 November 2003 to 30 April
2008. At a face-to-face meeting, and confirmed afterwards in
writing, surgeons were informed about the study including the
aims, inclusion and exclusion criteria, and recruitment procedures.
The surgeons were requested to include all patients: (a) aged
$18 years; (b) undergoing primary major amputation (at or
proximal to metatarsophalangeal level); and (c) able to read and
write in Dutch. The primary investigator discussed the study aims
PLOS ONE | www.plosone.org 1 August 2012 | Volume 7 | Issue 8 | e43629
with the patient and they were asked to participate and give their
written consent.
Exclusion criteria were: (a) had a previous ipsilateral amputa-
tion; (b) were too unwell or showed signs of clinical dementia
which prevented completion of the questionnaires, or (c) were
recruited more than 5 days after the amputation.
If the surgeons themselves decided to exclude a patient, they
agreed to send the characteristics of the patient (age, sex) and
amputation details (level, cause) to the primary investigator to
ensure a complete census of patients was recorded. The primary
investigator maintained regular contact with the study coordinator
at each hospital.
Population Study
In 2010, surgeons from each hospital were contacted about a
new study on the incidence of LLA. Surgeons from all hospitals
agreed to participate. They were requested to compile a list of
patients who underwent major amputation in 2004. The medical
records of these patients were reviewed between August 2010 and
July 2011 for patient data (age, sex), amputation details (level,
cause), marital status, comorbidities and medical history including
previous minor amputations or peripheral vascular procedures
(angioplasty, embolectomy or peripheral bypass) and survival or
date of death. To ensure a complete survival dataset, general
practitioners were contacted for patients whose status was not up
to date in hospital records.
Statistical Analysis
Characteristics of referred patients (irrespective of whether they
were included or excluded from analyses in the original study)
were compared with the non-referred patients using chi-square
tests for categorical variables, Mann-Whitney U test for age
distribution and log rank tests for survival. Significance was set at
0.05 and analyses were performed using PASW Statistics version
18.0.
Results
Surgeons representing 12 of 14 hospitals attended the informa-
tion meeting of the PP study. Two hospitals were unable to
participate because of restrictions from their local administration
and medical ethics procedures. Surgeons from ten hospitals agreed
to participate in recruitment of patients.
From the current study, one hospital was unable to identify the
relevant files because of changes in their database. This hospital
was excluded and subsequently, one patient from this hospital who
had been referred to the PP study was excluded.
Thirty nine (27%) of a possible 146 patients were referred
during the first full year of the study (table 1). The referred
population had a median age 8 years younger (p,0.001) and were
less likely to have had amputation because of a vascular condition,
diabetes or infection (p= 0.003) than those who were not referred.
More non-referred patients had bilateral amputation while more
referred patients had a knee disarticulation (p= 0.049). No
differences in the number or type of major co-morbidities were
seen, although referred patients were more likely to have had
undergone a previous vascular intervention (p = 0.042) such as a
peripheral bypass procedure or angioplasty. Referred patients
were more frequently discharged home or to a rehabilitation
centre with non-referred patients more often discharged to a care
centre (p = 0.020).
There was a significant difference in one year survival between
the groups; 67% of referred patients survived compared with 40%
of non-referred patients (p = 0.004). Overall survival time after
amputation also differed significantly (figure 1): median (standard
error) survival for referred group=41.1 (7.9) months, non-
referred = 13.6 (6.6) months, x2(1df) = 5.6; p = 0.018.
To verify whether or not the differences in the groups were
linked to the significantly poorer survival of the non-referred
population, characteristics of patients who survived to 12 months
are presented in table 2. There remained a significantly younger
median (p = 0.016) and mean (p= 0.007) age difference between
the referred and non-referred group. Again, the referred group
were more likely to have had a knee disarticulation, less likely to
have had a transtibial amputation (p = 0.041), and more frequently
had amputation because of non-vascular causes (0.012). There
were no other significant differences between the referred and
non-referred groups in 12 month survivors. Overall survival
differed by 9 months (median (standard error) survival for referred
group= 64.1 (14.7) months, non-referred= 55.6 (11.5) months,
x2(1df) = 1.8; p = 0.177) and non-referred patients were more
frequently discharged to a care center while referred patients were
more often discharged to a rehabilitation center (p = 0.130).
Discussion
A prospective study of phantom pain aimed to report all
patients undergoing primary major lower limb amputation yet
more than 70% of potential participants were not referred in the
first year. This resulted in a sample that was younger, less likely to
have had vascular related amputation and differed in both pre and
post care setting than the actual population who underwent LLA
[5].
The PP study described a prevalence rate for phantom pain of
32% measured 6 months after amputation [5]. Other literature
measuring occurrence at 6 months has reported more than double
this amount, with 65–79% of people having phantom pain
[13,14]. Occurrence rates at 6 months in trials to treat phantom
pain range from 0–38% (0/10 in intervention; 5/13 in control
group) [15] to 9–73% (1/11 in intervention; 8/11 in control) [16].
The PP study has a lower rate of phantom pain than expected
which raises some uncertainty in generalisation and clinical
application of the protective factors identified. These protective
factors should be considered within the context of the biased
population.
Three protective factors against the development of phantom
pain were described: being male, having a lower limb amputation
(versus an upper limb amputation) and time since amputation [5].
In the current study, there were no differences in sex between
referred and non-referred patients (upper limb amputations were
not included and only one year of the PP study was analysed).
Other factors in the PP study were also investigated but not found
to be significant, including level of amputation, cause of
amputation and age at time of amputation. None of these factors
were accurately represented by the sample referred to the PP study
and it is not possible to draw a valid conclusion over their
influence based only on this data.
The factors identified in the PP study were largely in
disagreement to other literature. In addition to prevalence rates
being much higher than the PP study, sex is reported as being
unrelated to occurrence of phantom pain [13,17] although males
and females may deal with the pain differently [18]. Increasing age
is shown as having a higher risk of phantom pain [19] while others
have reported no relation [17] or not included age in their analysis
[13]. More proximal amputation levels, and having bilateral
amputation, may increase a person’s risk of phantom pain [19]
although again others have found no association between the two
[13,20].
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The contradictory findings surrounding phantom pain in these
different populations are, at least in part, also partly attributable to
differences in definitions and study design. Cut-off points for what
constitutes phantom pain can include people with almost constant
Table 1. Characteristics of referred and non-referred patients and actual population.
n (%), unless stated otherwise Referred (PP study) Not referred p Actual population
Total included 39 (27) 107 (73) 146
Age, median (IQR)* 67.6 (50.8; 72.9) 75.5 (68.1; 83.3) ,0.001{ 73.0 (65.2; 80.9)
Age, mean (sd) 63.0 (13.9) 74.4 (12.0) ,0.001{ 71.4 (13.5)
Men 24 (62) 63 (59) 0.463 87 (60)
Cause of amputation
Vascular 31 (80) 101 (96) 0.003 132 (92)
Other 8 (21) 4 (4) 12 (8)
Level of amputation
bilateral 2 (5) 11 (10) 0.0491 13 (9)
transfemoral 12 (32) 32 (30) 44 (30)
knee disarticulation 7 (18) 5 (5) 12 (8)
transtibial 17 (45) 59 (55) 76 (52)
Admitted from
home 24 (75) 58 (62) 0.125 82 (65)
care 8 (25) 36 (38) 44 (35)
Marital status
married/partnership 21 (64) 42 (49) 0.118 63 (53)
single/widow/divorced 12 (36) 43 (51) 55 (47)
Number of comorbidities
0 7 (23) 9 (10) 0.171 16 (13)
1–2 15 (48) 56 (63) 73 (59)
$3 9 (29) 24 (27) 33 (28)
Type of comorbidities
peripheral vascular disease 21 (57) 54 (51) 0.320 75 (52)
hypertension 16 (42) 39 (36) 0.334 55 (38)
diabetes 14 (37) 45 (42) 0.358 59 (41)
congestive heart failure 6 (16) 26 (24) 0.217 32 (22)
myocardial infarct 5 (13) 14 (13) 0.593 19 (13)
cerebrovascular disease 3 (8) 17 (16) 0.185 20 (14)
chronic lung disease 8 (22) 18 (17) 0.335 26 (18)
kidney disease 9 (24) 21 (20) 0.376 30 (21)
Peripheral vascular procedure 23 (59) 44 (41) 0.042 67 (46)
Discharged to
home 10 (26) 16 (16) 0.020 26 (18)
rehabilitation centre 9 (23) 8 (8) 17 (12)
care 15 (39) 53 (52) 68 (48)
died before discharge 5 (13) 25 (25) 30 (21)
12 month survival 26 (67) 43 (40) 0.004 69 (47)
Hospital**
.10 amputations
29 (27) 80 (73) 0.960 109 (75)
#10 amputations 10 (27) 27 (73) 37 (25)
p is difference between referred and non-referred groups;
*Median age presented because data were not normally distributed, and mean age also presented to enable comparison to original PP Study;
{Mann Whitney U Test;
{Independent sample t-test; all others are Chi-square test;
1Exact method used as cell count assumptions not met;
**Comparison of hospitals where there were .10 (n = 6) amputations with #10 amputations (n = 7); Actual population is presented to enable comparison of
characteristics, no statistical analysis was performed; not all percentages add up to 100 because of rounding.
doi:10.1371/journal.pone.0043629.t001
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pain or people who experience only occasional pain [5]. Most
previous studies of phantom pain are cross sectional and direct
cause and effect cannot be stated. Studies include people with
differing lengths of time since amputation, from a few months to
many years [18,19,21], yet time since amputation is another factor
potentially linked to phantom pain. Poor physical condition from
co-morbidities and cognitive deficit leads to difficulties in patient
inclusion and sample sizes are generally small. As amputation
research is also characterised by a high mortality rate, follow up
rates are often low. In this study almost 50% of the total population
had died within 12 months of their first major amputation,
including 33% of the referred group. The PP study is the largest
longitudinal study of phantom pain performed (total included at
first follow up was 85 from 120 included) and followed patients for
up to 3.5 years [5]. Unfortunately, the substantial bias seen in the
population presents a major limitation and there remains limited
evidence around risk factors associated with phantom pain.
Reviews looking at mechanisms and treatment of phantom limb
pain reveal similar shortcomings in methodology [22–26].
A major difficulty with amputation outcome research is
obtaining large and representative samples. The reasons for
having an amputation make it difficult for many cases to be
included in research as elderly people with systemic disease tend
not to be considered for participation and have a higher rate of
drop out or death [1]. This appeared to be a key element of
(non)recruitment to the PP study, with patients who were older
and with amputation due to vascular disease least likely to be
referred. Data, or at least their estimates, on non-participants
(including people who did not give consent, patients who are
excluded, deaths and drop outs) should be communicated by
authors. In the PP study, all referral sources were requested to
provide this information, but unfortunately it did not occur.
Minimal data presented in amputation research should include the
number of participants and non-participants, age, sex, level of
amputation and cause of amputation.
Our data were split to look at 12 month ‘non-survivors’
compared to ‘survivors’. With outcomes of interest for the ‘frailer’
group likely differing from the survivors, it is reasonable that they
are not included in longitudinal outcome research. Unfortunately,
our results showed that a substantial number of this healthier
group, the 12-month survivors, also failed to be included in the PP
study. In designing any study, gaining strong interest and support
from relevant stakeholders and referral sources is vital. In the case
of the PP study, referral sources (surgeons and staff) were informed
of the aims and methodology at a regional meeting, with verbal
agreements given for participation (referral of patients). The high
referral rate (.85% of all within hospital, contributing .69% of
all referred) from the study’s operating/base hospital, suggests
either the physical presence of the investigator and/or simply
being the study’s main location are the most effective strategies for
recruitment. Across the entire regional network of hospitals, a
physical presence was not possible. Attempts to counter this
limitation through regular phone and newsletter contact were
unsuccessful, with 6 hospitals not referring patients in the first year
Figure 1. Survival of patients referred and not referred to study after lower limb amputation.
doi:10.1371/journal.pone.0043629.g001
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despite their agreement. Improving recruitment via clinicians is a
difficult task; even large randomised controlled trials have great
difficulty identifying successful strategies [27]. Adding to this are
strict timeframes of the inclusion criteria of the PP study with
referral set for within 5 days. This meant that surgeons (and their
staff) were primarily responsible for identifying cases, at a time
when other factors, such as pre-operative assessment, can naturally
be of a greater priority. It is not routine practice for the
rehabilitation physician to be involved pre-surgically so this
additional referral source was not utilised. Other alternatives were
not considered as clinically relevant options, such as extending the
inclusion period to .5 days, as this would have introduced
problems with recall.
Limitations
The population study used data from a retrospective review of
medical files and as such, informationwas limited towhat is included
in these. The data were collected for a concurrent study on incidence
and as such, they are considered to be complete. However, we
acknowledge that cases may have been missed. If anything, the
sample is an underestimation, although we do not expect that this
would have any large affect on ourmain findings. Another limitation
from the study design (review ofmedical records) is not having access
to information on disease severity or duration of disease. Further,
unless it is of a very severe nature, cognitive status is infrequently
noted in themedical files. However, this is likely to be amajor source
of selection bias in LLA research given that vascular disease affects
the body systemically. Finally, there was no information on survival
status available for 27 patients and our results are likely to be an
underestimate of survival time.
In the current study, all patients referred to the PP study were
considered as one group. However, 16 (41%) of these patients
were not part of the analyses as they did not meet the criteria for
inclusion. These excluded patients were older and more likely to
have had amputation because of vascular disease than included
patients [5]. The findings of this current study should therefore be
considered as a conservative estimate of the impact of selection
bias as these excluded older patients with vascular disease
remained within the ‘referred’ group.
Conclusion
Selection bias is common, and perhaps inherent, in amputation
research. Over 70% of patients were missed in a study of phantom
pain, resulting in a younger population who were less likely to have
had vascular related amputation and differed in respect to their
pre- and post-care setting. As a result, phantom pain was possibly
underestimated and the resultant protective factors identified
should be considered only within the context of the biased
population. Two important elements for improving research into
amputation outcomes were identified: (a) failure to refer relevant
cases (recruitment bias); and (b) failure to communicate reasonable
non-inclusions. Potential bias should be more clearly presented by
authors and subsequent conclusions and clinical decisions made
with greater caution. In addition, maximum efforts should be
directed to research methodology which minimises the influence of
bias.
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